164.94

+0.29%↑

96.76

+1.03%↑

BMO

137.56

+0.21%↑

97.99

+0.98%↑

BNS

69.84

-0.64%↓

164.94

+0.29%↑

96.76

+1.03%↑

BMO

137.56

+0.21%↑

97.99

+0.98%↑

BNS

69.84

-0.64%↓

164.94

+0.29%↑

96.76

+1.03%↑

BMO

137.56

+0.21%↑

97.99

+0.98%↑

BNS

69.84

-0.64%↓

164.94

+0.29%↑

96.76

+1.03%↑

BMO

137.56

+0.21%↑

97.99

+0.98%↑

BNS

69.84

-0.64%↓

164.94

+0.29%↑

96.76

+1.03%↑

BMO

137.56

+0.21%↑

97.99

+0.98%↑

BNS

69.84

-0.64%↓

Kodu・Aktsiate loetelu・Walker & Dunlop Inc

Walker & Dunlop Inc

Avatud

SektorRahandus

44.79 -0.86

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

44.22

Max

45.35

Põhinäitajad
By Trading Economics
Sissetulek	-47M -14M
Müük	2.3M 340M
P/E Sektori keskmine	26.518 55.155
Dividenditootlus	6.23
Kasumimarginaal	-4.087
Töötajad	1,466
EBITDA	-46M 60M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+46.26% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	6.23% 4.95%
Järgmine tulemuste avaldamine	30. apr 2026
Järgmine dividendimakse kuupäev	28. mai 2026
Järgmine aktsia dividendi kuupäev (ex-date)	14. mai 2026

Turustatistika
By TradingEconomics
Turukapital	-606M 1.5B
Eelmine avamishind	45.65
Eelmine sulgemishind	44.79

Uudiste sentiment

By Acuity

50%

160 / 440 Pingereas Finance

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

70.995 / 76.69 Toetus ja vastupanu

Walker & Dunlop Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. apr 2026, 23:17 UTC

Tulu

Samsung Forecasts Record First-Quarter Operating Profit

6. apr 2026, 23:00 UTC

Kuumad aktsiad

Stocks to Watch: Health Insurers, Mawson, Owlet

6. apr 2026, 22:13 UTC

Suurimad hinnamuutused turgudel

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6. apr 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6. apr 2026, 17:09 UTC

Suurimad hinnamuutused turgudel

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6. apr 2026, 16:56 UTC

Uudisväärsed sündmused

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6. apr 2026, 14:47 UTC

Suurimad hinnamuutused turgudel

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7. apr 2026, 00:00 UTC

Uudisväärsed sündmused

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6. apr 2026, 23:58 UTC

Market Talk

Uudisväärsed sündmused

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6. apr 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6. apr 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6. apr 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6. apr 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6. apr 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6. apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6. apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6. apr 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6. apr 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6. apr 2026, 18:36 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 17:59 UTC

Market Talk

Uudisväärsed sündmused

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6. apr 2026, 17:13 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6. apr 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. apr 2026, 14:59 UTC

Tulu

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Võrdlus sarnastega

Hinnamuutus

Walker & Dunlop Inc Prognoos

Hinnasiht

By TipRanks

46.26% tõus

12 kuu keskmine prognoos

Keskmine 65 USD 46.26%

Kõrge 65 USD

Madal 65 USD

Põhineb 1 Wall Streeti analüütiku instrumendi Walker & Dunlop Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Walker & Dunlop Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

70.995 / 76.69Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bearish.

There are no events.

Sentiment

By Acuity

160 / 440 Pingereas Rahandus

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Walker & Dunlop Inc

Walker & Dunlop, Inc. is a holding company, which conducts its operations through Walker & Dunlop, LLC. The Company provides commercial real estate and financial services. It originates, sells, and services a range of commercial real estate debt and equity financing products and provides multifamily property sales brokerage and valuation services. It is also engaged in commercial real estate investment management activities. The Company provides housing market research and delivers real estate-related investment banking and advisory services. Through its agency products, the Company originates and sells loans pursuant to the programs of the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Federal Housing Administration. Through its debt brokerage products, the Company brokers, and in some cases services, loans for various life insurance companies, commercial banks, commercial mortgage-backed securities issuers and other institutional investors.